Pacific Edge shares tumble 14% after FY net loss

Pacific Edge shares tumble 14% after FY net loss
Rebecca Howard
By Rebecca Howard May 29 (BusinessDesk) - Pacific Edge's shares fell 14 percent, despite reporting a smaller full year net loss as more people adopted its Cxbladder cancer diagnostics tests. The shares dropped to 18.5 cents after the Dunedin-based company reported a loss of $17.9 million in the year to March 31, versus a loss of $19.7 million in the prior year. Operating revenue from test sales was up 12 percent to $3.8 million while total revenue was up 3 percent to $5.1 million.  The company has developed non-invasive, accurate and s...

More Services

$1.65b project to simplify switching banks a 'flop'
Finance

$1.65b project to simplify switching banks a 'flop'

Open banking has hindered competition rather than helping it, says lobby.

AAP 04 Jul 2024
Hundreds of ECE centres backtracking on pay parity
Policy

Hundreds of ECE centres backtracking on pay parity

96% of daycares have opted into pay parity, but govt funding doesn't match the costs.

Demand pricing may be coming to a movie theatre near you
Markets

Demand pricing may be coming to a movie theatre near you

NZX-listed Vista is rolling out a suite of AI innovations.

Govt 'will consult' on NZ Post review, minister says
Services

Govt 'will consult' on NZ Post review, minister says

The deadline for a review of the postal service is up this month.

Maria Slade 14 Jun 2024